Abstract
This paper aims to review the application of digital platforms in the assessment and monitoring of patients with Bipolar Disorder (BPD). We will detail the current clinical criteria for the diagnosis of BPD and the tools available for patient assessment in the clinic setting. We will go on to highlight the difficulties in the assessment and monitoring of BPD patients in the clinical context. Finally, we will elaborate upon the impact that diital platforms have made, and have the potential to make, on healthcare, mental health, and specifically the management of BPD, before going on to evaluate the benefits and drawbacks of the use of such technology.
Highlights
Bipolar disorder (BPD) is a psychiatric illness with a significant global burden, with an incidence rate of 2.6% in United States [1,2]
The high global prevalence of BPD is associated with significant costs
While advances in drug treatment for this disorder remain modest at best, substantial progress has been made in the development of adjunctive psychosocial interventions [10]
Summary
Bipolar disorder (BPD) is a psychiatric illness with a significant global burden, with an incidence rate of 2.6% in United States [1,2]. The disorder is reported to have an aggregate lifetime prevalence of 2.4% [3]. The disease burden is slightly lower in Singapore, with a reported prevalence of 1.2%. The high global prevalence of BPD is associated with significant costs. The total economic burdens of the disorder in the US and UK in 1991 were estimated at USD 45 billion and GBP 2 billion, respectively [4,5]. The aetiology of BPD is still unclear but various biochemical, pharmacological, anatomical, and genetic theories have been postulated [6]. This paper will review the diagnosis, assessment, and monitoring of BPD and the use of digital platforms in these endeavours
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have